Abstract
Bone metastases in patients with prostate cancer are common. Prostate cancer patients also have a relatively long survival. Palliative radiation can provide effective symptom control in many clinical settings. This article focuses on the management of bone pain and its complications (pathological fractures and spinal cord compression) with radiation treatment.
Similar content being viewed by others
References
Whitmore WJ Jr (1984) Natural history and staging of prostate cancer. Urol Clin North Am 11:209–220
Chodak G, Thisted R, Gerber G, et al. (1994) Results of conservative management of clinically localized prostate cancer. N Engl J Med 330:242–248
Batson O (1940) The function of the vertebral veins and their role in the spread of metastases. Ann Surg 112:138–149
Dodds P, Caride V, Lytton B (1981) The role of vertebral veins in the dissemination of prostatic carcinoma. J Urol 126:753–755
Perez C (1997) Prostate. In: Perez C, Brady L (eds) Principles and practice of radiation oncology. Lippincott-Raven, Philadelphia, pp 1583–1694
McCarthy P, Pollack H (1991) Imaging of patients with stage D prostatic carcinoma. Urol Clin North Am 18:35–53
Allen K, Johnson T, Hibbs G (1976) Single-dose irradiation of bone metastases. Acta Radiol Ther Phys Biol 15:337–339
Arcangeli G, Micheli A, Arcangeli G, et al. (1989) The responsiveness of bone metastasis to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 14:95–101
Garmatis C, Chu F (1978) The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer. Radiology 16:235–237
Gilbert R, Kim J, Posner J (1978) Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 3:40–51
Jensen N, Roesdahl K (1976) Single-dose irradiation of bone metastases. Acta Radiol Ther Phys Biol 15:337–339
Kumar P, Bahrassa F, Espinoza M (1978) The role of radiotherapy in management of metastatic bone disease. J Natl Med Assoc 70:909–911
Schocker J, Brady L (1982) Radiation therapy for bone metastases. Clin Orthop 169:38–43
Vargha Z, Glicksman A, Beland J (1969) Single-dose radiation therapy in the palliation of metastatic disease. Radiology 93:1181–1184
Qasim M (1977) Single-dose palliative irradiation for bony metastases. Strahlentherapie 153:531–532
Tong D, Gillick L, Hendrickson F (1982) The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 50:893–899
Blitzer P (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastases. Cancer 55:1468–1472
Price P, Hoskin P, Easton D, et al. (1986) Prospective randomized trial of single and multi-fraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6:247–255
Hoskin PJ, Price P, Easton D, et al. (1992) A prospective randomized trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 23:74–78
Bone Pain Trial Working Party (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomized comparison with multi-fraction schedule over 12 months of patient follow-up. Radiother Oncol 52:111–121
Steenland E, Leer J, van Houwelingen H, et al. (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101–109
Nielsen O, Bentzen S, Sandberg E, et al. (1998) Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47:233–240
Jeremic B, Shibamoto Y, Acimovic L, et al. (1998) A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42:161–167
Gaze M, Kelly C, Kerr G, et al. (1997) Pain relief and quality of life following radiotherapy for bone metastases: a randomized trial of two fractionation schedules. Radiother Oncol 45:109–116
Niewald M, Tkocz H, Abel U, et al. (1996) Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 36:1085–1089
Ratanatharathorn V, Powers W, Moss W, et al. (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 44:1–18
Chow E, Danjoux C, Wong R, et al. (2000) Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol 56:305–314
Duncan G, Duncan W, Maher EJ (1993) Patterns of palliative radiotherapy in Canada. Clin Oncol 5:92–97
Ben-Josef E, Shamsa F, Williams A, et al. (1998) Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Phys 40:915–921
Hartsell W, Shah A, Graney M, et al. (1998) Palliation of bone metastases in the USA: a survey of patterns of practice (abstract 45). Support Care Cancer 6:175
Bentzen S, Hoskin P, Roos D, et al. (2000) Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or ...? Int J Radiat Oncol Biol Phys 46:681–682
Chow E, Danjoux C, Connolly R, et al. (2000) Bone metastasis: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. Int J Radiat Oncol Biol Phys 46:517–518
Ratanatharathorn V, Powers W, Moss W, et al. (2000) Response to the letter from Dr. Edward Chow and associates to the editor. Int J Radiat Oncol Bio Phys 46:518
Ratanatharathorn V, Powers W, Moss W, et al. (2000) In response to Dr. Bentzen et al. Int J Radiat Oncol Biol Phys 46:682–683
Needham P, Mithal N, Hoskin P (1994) Radiotherapy for bone pain. J R Soc Med 87:503–505
Wu J, Wong R, Johnston M, et al. on behalf of the Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases Int J Radiat Oncol Biol Phys 55:594–605
van den Hout W, van der Linden Y, Steenland E, et al. for the Dutch Bone Metastasis Study Group (2003) Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 95:222–229
Fitzpatrick P, Rider W (1976) Half body irradiation. Int J Radiat Oncol Biol Phys 1:197–207
Hoskin P, Ford H, Harmer C (1989) Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients. Clin Oncol 1:67–69
Kuban D, Delbridge T, El-Mahdi A, et al. (1989) Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate. J Urol 141:572–574
Salazar O, Rubin P, Hendrickson F, et al. (1986) Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. final radiation therapy oncology group report. Cancer 58:29–36
Dearnaley D, Bayly R, A'Hern R, et al. (1992) Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Clin Oncol 4:101–107
Priestman T, Roberts J, Lucraft H, et al. (1990) Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol 2:71–75
Quilty P, Kirk D, Bolger J, et al. (1994) A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 31:33–40
Van Dyk J, Keane T, Kan S, et al. (1981) Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys 7:461–467
Zelefsky M, Scher H, Forman J, et al. (1989) Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens. Int J Radiat Oncol Biol Phys 17:1281–1285
Poulter C, Cosmatos D, Rubin P, et al. (1992) A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 23:207–214
Salazar O, Sandhu T, Da Motta N, et al. (2001) Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized phase III trial of the international atomic energy agency (IAEA). Int J Radat Oncol Biol Phys 50:765–775
Eary J, Collins C, Stabin M, et al. (1993) Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 34:1031–1036
McEwan A (2000) Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 10:103–114
Porter A, McEwan A, Powe J (1993) Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 25:805–813
Porter A, McEwan A (1993) Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial. Semin Oncol 20:38–43
Blake G, Zivanovic M, Blaquiere R, et al. (1988) Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med 29:549–557
Breen S, Powe J, Porter A (1992) Dose estimation of strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med 33:1316–1323
Blake G, Wood J, Wood P, et al. (1989) Sr therapy: strontium plasma clearance in disseminated prostatic carcinoma. Eur J Nucl Med 15:49–54
Lewington V, McEwan A, Ackery D, et al. (1991) A prospective randomized double-blind crossover study to examine the efficacy of strontium-89 pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 27:954–958
Buchali K, Correns H, Schuerer M, et al. (1988) Results of a double-blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med 14:349–351
McEwan A, Amyotte G, McGowan D, et al. (1994) A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone. Nucl Med Commun 15:499–504
Malmberg I, Persson U, Ask A, et al. (1997) Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy. Urology 50:747–753
Finkelstein E, Veldkamp L (2001) Effect of external beam irradiation on the uptake and distribution of samarium-153 EDTMP. Int J Radiat Oncol Biol Phys 51 [Suppl 1]:237–238
Tian J, Zhang J, Hou Q, et al. (1999) Multi-centre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Eur J Nucl Med 26:2–7
Dickie GJ, Macfarlane D (1999) Strontium and samarium therapy for bone metastases from prostate carcinoma. Australas Radiol 43:476–479
Sartor O, Bushnell D, Reid R, Quick D (2001) Repeated administration of Sm-153-Lexidronam in the treatment of painful bone metastases (abstract 1036). Proc ASCO 20
Resche I, Chatal J-F, Pecking A, et al. (1997) A dose-controlled study of 153 SM-ethylene diaminectetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 33:1583–1591
Serafini AN, Houston SJ, Resche I, et al. (1998) Palliation of pain associated with metastatic bone cancer using Samarium-153 Lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16:1574–1581
Sartor O, Quick D, Reid R, et al. (1997) A double blind placebo-controlled study of 153-samarium-EDTMP for palliation of bone pain in patients with hormone-refractory prostate cancer (abstract 1252). 92nd Annual Meeting of the American Urological Association
Parkes CM (1972) Accuracy of predictions of survival in later stages of cancer. Br Med J 2:29–31
Forster LE, Lynn J (1988) Predicting life span for applicants to in-patient hospice. Arch Intern Med 148:2540–2543
Townsend PW, Rosenthal HG, Smalley SR, et al. (1994) Impact of post-operative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathological fractures due to metastatic disease. J Clin Oncol 12:2345–2350
Pouslen HS, Nielson OS, Klee M, Rorth M (1989) Palliative irradiation of bone metastases. Cancer Treat Rev 16:41–48
Sylvester JE, Greenberg P, Selch MT, Thomas BJ, Amstutz H (1988) The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement. Int J Radiat Oncol Biol Phys 14:471–476
Blake DD (1970) Radiation treatment of metastatic bone disease. Clin Orthop 73:89–100
Ford HT, Yarnold JR (1983) Radiation therapy—pain relief and recalcification. In: Toll BA, Parbhoo S (eds) Bone metastases: monitoring and treatment. Raven Press, New York, pp 343–354
Schmidt RG (1995) Management of extremity metastatic bone cancer. Curr Probl Cancer 19:166–182
Galasko CS (1988) The role of the orthopaedic surgeon in the treatment of bone pain. Cancer Surv 7:103–125
Habermann ET, Lopez RA (1989) Metastatic disease of bone and treatment of pathological fractures. Orthop Clin North Am 20:469–486
Katzner M, Schvingt E (1989) Bone metastases of breast cancer. Surgical treatment of 228 sites in the limbs (in French). Chirurgie 115:741–750
Schurman DJ, Amstutz HC (1973) Orthopedic management of patients with metastatic carcinoma of the breast. Surg Gynecol Obstet 137:831–836
Snell W, Beals RK (1964) Femoral metastases and fractures from breast cancer. Surg Gynecol Obstet 119:22–24
Beals RK, Lawton GD, Snell WE (1971) Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 28:1350–1354
Menck H, Schultze S, Larsen E (1988) Metastasis size in pathologic femoral fractures. Acta Orthop Scand 59:151–154
Ryan JR, Rowe DE, Salciccioli GG (1976) Prophylactic internal fixation of the femur for neoplastic lesions. J Bone Joint Surg 58:1071–1074
Fidler M (1973) Prophylactic internal fixation of secondary neoplastic deposits in long bones. Br Med J I:341–343
Fidler M (1981) Incidence of fracture through metastases in long bones. Acta Orthop Scand 52:623–627
Mirels II (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 249:256–264
Bertin KC, Horstman J, Coleman S (1984) Isolated fracture of the lesser trochanter in adults. An initial manifestation of metastatic malignant disease. J Bone Joint Surg 66:770–773
Phillips CD, Pope TJ Jr, Jones JF (1988) Nontraumatic avulsion of the lesser trochanter: a pathognomonic sign of metastatic disease. Skeletal Radiol 17:106–110
Jardines L, Callans LS, Torosian MH (1993) Recurrent breast cancer: presentation, diagnosis, and treatment. Semin Oncol 20:538–547
Gristina AG, Adair DM, Spurr CL (1983) Intraosseous metastatic breast cancer treatment with internal fixation and study of survival. Ann Surg 197:128–134
Tan JL, Lo NN, Tan SK (1992) Surgical treatment of metastatic long bone disease. Singapore Med J 33:355–358
Yasawa Y, Frassica FJ, Chao EY, et al. (1990) Metastatic bone disease. Clin Orthop 251:213–219
Hardman PD, Robb JE, Kerr GR, et al. (1992) The value of internal fixation and radiotherapy in the management of upper and lower limb bone metastases. Clin Oncol 4:244–248
Cheng DS, Seitz CB, Eyre HJ (1980) Nonoperative management of femoral, humeral, and acetabular metastases in patients with breast carcinoma. Cancer 45:1533–1537
Bessler W, Weber S (1977) Die Strahlenbehandlung von Knochenmetastasen bei Mammacarcinom. Schweiz Rundsch Med Prax 66:140
Garmatis GJ, Chu FCH (1978) The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer. Radiology 126:235
Koswig S, Budach V (1999) Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study (in German). Strahlenther Onkol 175:500–508
Loblaw DA, Zhou S, Laperriere NJ, Mackillop WJ (1999) A population-based study of malignant spinal cord compression, presented at 41st Annual Meeting of the American Society of Radiation Oncology Biology and Physics, San Antonio (abstract 2102). Int J Radiat Oncol Biol Phys 45:329
Gilbert RW, Kim J-H, Posner JB (1978) Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 3:40–51
Helweg-Larsen S (1996) Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients. Acta Neurol Scand 94:264–275
Loblaw DA, To T, Cohen M, Laperriere NJ, Detsky AS (2002) The accuracy of a linked administrative database of malignant spinal cord compression in Ontario cancer patients, presented at Annual Meeting of the Canadian Association of Radiation Oncology, Toronto, 2002 (abstract 144). Radiother Oncol 65 [Supp1]:S34
Loblaw DA, To T, Cohen M, Laperriere NJ, Detsky AS (2002) The accuracy of a linked administrative database of malignant spinal cord compression in Ontario cancer patients. Department of Health Promotion, Management and Evaluation. University of Toronto, Toronto
Talcott JA, Stomper PC, Drislane FW, et al. (1999) Assessing suspected spinal cord compression. A multidisciplinary outcomes analysis of 342 episodes. Support Care Cancer 7:31–38
Loblaw DA, Laperriere NJ, Mackillop WJ (2000) Who should be screened for malignant spinal cord compression? Defining a high-risk population (abstract 142). Clin Invest Med 23:S23
Bayley A, Milosevic M, Gospodarowicz M, Blend R (2001) A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate cancer. Cancer 92:303–310
Loblaw DA, Laperiere NJ (1998) Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 16:1613–1624
Loblaw DA, Laperriere NJ, Chambers A, Perry J, Group at CCOPGIN-ODS (2003) Diagnosis and management of malignant epidural spinal cord compression (Evidence Summary Report No. 9–9). Cancer Care Ontario, 2003. http://www.ccopebc.ca./neucpg.html. Accessed: 4 April 2003
Pigott KH, Baddeley H, Maher EJ (1994) Pattern of disease in spinal cord compression on MRI scan and implications for treatment. Clin Oncol 6:7–10
Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY (1992) Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer 70:2319–2325
Gonzalez-Barcena D, Vadillo-Buenfil M, Cortez-Morales A, et al. (1995) Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord. Urology 45:275–281
Cassileth BR SE, Soloway MS, et al. (1989) Patients' choice of treatment in stage D prostate cancer. Urology 33:57–62
Bubley GJ (2001) Is the flare phenomenon clinically significant? Urology 58:5–9
Bok RA, Small EJ (1999) The treatment of advanced prostate cancer with ketoconazole: safety issues. Drug Saf 20:451–458
Maranzano E, Latini P, Beneventi S, et al. (1998) Comparison of two different kinds of radiotherapy schedules for spinal cord compression. Tumori 84:472–477
Maranzano E, Latini P (1995) Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 32:959–967
Maranzano E, Latini P, Perrucci E, Beneventi S, Lupattelli M, Corgna E (1997) Short-course radiotherapy (8 Gy ×2) in metastatic spinal cord compression: an effective and feasible treatment. Int J Radiat Oncol Biol Phys 38:1037–1044
Ghogawala Z, Mansfield FL, Borges LF (2001) Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine 26:818–824
Schiff D, Shaw EG, Cascino TL (1995) Outcome after spinal reirradiation for malignant epidural spinal cord compression. Ann Neurol 37:583–589
Wong CS, Van Dyk J, Milosevic M, et al. (1994) Radiation myelopathy following single courses of radiotherapy and retreatment. Int J Radiat Oncol Biol Phys 30:197–202
Loblaw DA, Smith K, Lockwood G, Carolan H, Laperriere NJ (2003) The Princess Margaret Hospital experience of malignant spinal cord compression. Proc ASCO
Kim RY, Spencer SA (1990) Extradural spinal cord compression: analysis of factors determining functional prognosis—prospective study. Radiology 176:279–282
Helwig-Larsen S, Sorensen PS, Kreiner S (2000) Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46:1163–1169
Rades D, Heidenreich F, Karstens JH (2002) Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 53:975–979
Maranzano E, Latini P, et al. (1991) Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Ann Neurol 3:40–51
Maranzano E, Latini P, Beneventi S, et al. (1996) Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial. Am J Clin Oncol 19:179–183
Ampil FL, Chin HW (1995) Radiotherapy alone for extradural compression by spinal myeloma. Radiat Med 13:129–131
Kovner F, Spigel S, Rider I, et al. (1999) Radiation therapy of metastatic spinal cord compression. J Neurooncol 42:85–92
Greenberg HS, Kim JH, Posner JB (1980) Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 8:361–366
Bubendorf L, Schopfer A, Wagner U, et al. (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578–583
Nakamachi H, Suzuki H, Akakura K, et al. (2003) Clinical significance of pulmonary metastases in stage D2 prostate cancer patients. Prostate Cancer Prostatic Dis 5:159–163
McCutcheon IE, Eng DY, Logothetis CJ (1999) Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatment. Cancer 86:2301–2311
Rubenstein JH, Katin MJ, Mangano MM, et al. (1997) Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 20:376–380
Fabozzi SJ, Schellhammer PF, el-Mahdi AM (1995) Pulmonary metastases from prostate cancer. Cancer 75:2706–2709
Taylor HG, Lefkowitz M, Skoog SJ, et al. (1984) Intracranial metastases in prostate cancer. Cancer 53:2728–2730
Sneed PK, Suh JH, Goetsch SJ, et al. (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526
O'Neill BP, Iturria NJ, Link MJ, et al. (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55:1169–1176
Perez CA, Cosmatos D, Garcia DM, Eisbruch A, Poulter CA (1993) Irradiation in relapsing carcinoma of the prostate. Cancer 71 [Suppl]:1110–1122
Leibel SA, Pajak TF, Massullo V, et al. (1987) A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13:1057–1064
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chow, E., Wu, J., Loblaw, A. et al. Radiotherapeutic approaches to metastatic disease. World J Urol 21, 229–242 (2003). https://doi.org/10.1007/s00345-003-0359-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-003-0359-7